An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

書目詳細資料
主要作者:	Bristy, Israt Zerin
其他作者:	Kabir, Md. Tanvir
格式:	Thesis
語言:	English
出版:	Brac University 2021
主題:	Covid-19 Lung carcinoma Genetic mutation Chemotherapy Immunotherapy Lungs > Cancer Oncology
在線閱讀:	http://hdl.handle.net/10361/15619

相似書籍

Molecules associated with the development of lung cancer
由: Rahman, Adree, et al.
出版: (2023)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
由: Shabnam, Musharrat
出版: (2018)

Immunotherapy in the Management of Lung Cancer
由: Tasnim, Humayra
出版: (2022)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
由: Paul, Pulock
出版: (2024)

Potential of liposomes for the treatment of lung cancer- a review
由: Mim, Shanzida
出版: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
由: Jeba, Joynob
出版: (2017)

A review on recent advances in drugs for lung cancer treatment
由: Noor, Fouzia
出版: (2024)

A review on targeted therapies for lung cancer
由: Ashraf, Anushey
出版: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
由: Zangmo, Thinley
出版: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
由: Tania, Umme
出版: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
由: Rahman, Sanjida
出版: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
由: Rahman, Tasnim
出版: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
由: Razna, Amrin Islam
出版: (2019)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
由: Hoque, Ismoth Ara
出版: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
由: Pial, Sazia Afrin
出版: (2018)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
由: Mukti, Roushney Fatima, et al.
出版: (2016)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
由: Flora, Sanzida Alam
出版: (2024)

Immunotherapy in the treatment of renal cancer
由: Shimu, Sumaya
出版: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
由: Das, Reshita
出版: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
由: Abir, Shifaty Nur
出版: (2024)

Lung cancer detection and classification using machine learning
由: Arefin, Mahbubul, et al.
出版: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
由: Nandy, Aditi
出版: (2022)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
由: F. S. Amaral, André, et al.
出版: (2017)

Current practice and approaches of immunotherapy in Cancer treatment
由: Khondokar, Faiza
出版: (2022)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A localized drug delivery approach to treat peritoneal carcinomatosis of different origins
由: Afrin, Sabrina
出版: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
由: Auvy, Akib Al Mahmud, et al.
出版: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
由: Karim, Samia Binte
出版: (2024)

Deep 3D convolutional neural network in early detection of Lung cancer
由: Hossain, Khandoker Jobayer, et al.
出版: (2019)

A review on CRISPR-Cas system based applications in Oncology
由: Sadia, Mir
出版: (2022)

Smart biomedical device to predict lung diseases, COVID-19 and diabetes by using machine learning algorithms
由: Hossain, Ashraful, et al.
出版: (2024)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
由: Rithin, Rafia Islam
出版: (2022)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
由: Sakib, Hasibul, et al.
出版: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
由: Mirza, Maisa Tasnim
出版: (2023)

CAR-T cell Therapy in B-cell Lymphoma
由: Faruk, Asef
出版: (2020)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
由: Chowdhury, Maisha Mosharrat
出版: (2018)

Dendritic cell vaccine for the treatment of cancer
由: Haque, Tanzila
出版: (2023)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
由: Monayem, Kazi Fahim
出版: (2024)

The uses of bacteria in cancer therapy
由: Saha, Shimul, et al.
出版: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
由: Rahman, Samia
出版: (2022)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
由: Raihan, Dilraj
出版: (2024)